Payment overview · 2025
General Payments
$324.44
22 reported records · 5 companies
Healthcare provider profile · identity verified
James Ruhlmann, MD
Allopathic & Osteopathic Physicians|Internal Medicine · HUTCHINSON, KS · NPI 1316919426
Verified facts
What the public records show
CMS Open Payments records show James Ruhlmann, MD received $324.44 in general payments during 2025 across 22 reported records.
Novo Nordisk Inc accounted for 78.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 86 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $255.07 | 78.6% | 18 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $21.05 | 6.5% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $19.10 | 5.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.15 | 4.7% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.07 | 4.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $324.44 | 22 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $217.66 | 15 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $184.49 | 13 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $19.10 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.15 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.07 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $14.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 86 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
86 | 20 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1091 | 263 |
| Losartan Potassium | Losartan Potassium | 1055 | 271 |
| Levothyroxine Sodium | Levothyroxine Sodium | 876 | 195 |
| Pantoprazole Sodium | Pantoprazole Sodium | 742 | 175 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 717 | 199 |
| Omeprazole | Omeprazole | 609 | 145 |
| Gabapentin | Gabapentin | 601 | 137 |
| Furosemide | Furosemide | 587 | 148 |
| Amlodipine Besylate | Amlodipine Besylate | 533 | 153 |
| Lisinopril | Lisinopril | 503 | 127 |
| Potassium Chloride | Potassium Chloride | 432 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 398 | 101 |
| Simvastatin | Simvastatin | 388 | 109 |
| Metformin Hcl | Metformin Hcl | 374 | 92 |
| Warfarin Sodium | Warfarin Sodium | 358 | 34 |
| Sertraline Hcl | Sertraline Hcl | 348 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 348 | 98 |
| Hydrochlorothiazide | Hydrochlorothiazide | 278 | 66 |
| Meloxicam | Meloxicam | 273 | 84 |
| Montelukast Sodium | Montelukast Sodium | 249 | 51 |
| Trazodone Hcl | Trazodone Hcl | 239 | 47 |
| Glimepiride | Glimepiride | 222 | 66 |
| Finasteride | Finasteride | 220 | 52 |
| Eliquis | Apixaban | 204 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 197 | 48 |
| Spironolactone | Spironolactone | 190 | 45 |
| Clonazepam | Clonazepam | 182 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 173 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 165 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 164 | 48 |
| Duloxetine Hcl | Duloxetine Hcl | 162 | 34 |
| Alprazolam | Alprazolam | 158 | 35 |
| Quetiapine Fumarate | Quetiapine Fumarate | 158 | 31 |
| Tramadol Hcl | Tramadol Hcl | 158 | 48 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 154 | 49 |
| Alendronate Sodium | Alendronate Sodium | 149 | 38 |
| Carvedilol | Carvedilol | 148 | 35 |
| Topiramate | Topiramate | 135 | 26 |
| Allopurinol | Allopurinol | 134 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 133 | 28 |
| Donepezil Hcl | Donepezil Hcl | 123 | 31 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 120 | 32 |
| Lorazepam | Lorazepam | 116 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 114 | 40 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 113 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 113 | 31 |
| Atenolol | Atenolol | 109 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 109 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 104 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 102 | 17 |
| Trulicity | Dulaglutide | 98 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 96 | 26 |
| Mirtazapine | Mirtazapine | 95 | 16 |
| Levetiracetam | Levetiracetam | 88 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 87 | 20 |
| Ozempic | Semaglutide | 86 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 85 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 78 | 19 |
| Prednisone | Prednisone | 78 | 44 |
| Ezetimibe | Ezetimibe | 76 | 23 |
| Azithromycin | Azithromycin | 75 | 69 |
| Doxazosin Mesylate | Doxazosin Mesylate | 71 | 16 |
| Bupropion Xl | Bupropion Hcl | 70 | 14 |
| Metformin Hcl Er | Metformin Hcl | 70 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 69 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 69 | 15 |
| Mounjaro | Tirzepatide | 69 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 19 |
| Famotidine | Famotidine | 66 | 17 |
| Fenofibrate | Fenofibrate | 66 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 66 | 16 |
| Klor-Con M20 | Potassium Chloride | 62 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 60 | 53 |
| Ropinirole Hcl | Ropinirole Hcl | 59 | 12 |
| Baclofen | Baclofen | 58 | 11 |
| Estradiol | Estradiol | 53 | 14 |
| Synthroid | Levothyroxine Sodium | 53 | 13 |
| Xarelto | Rivaroxaban | 53 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 50 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 50 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 48 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 48 | 15 |
| Terazosin Hcl | Terazosin Hcl | 48 | 14 |
| Nortriptyline Hcl | Nortriptyline Hcl | 47 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 47 | 15 |
| Pregabalin | Pregabalin | 46 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 46 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 45 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 43 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 42 | suppressed |
| Lamotrigine | Lamotrigine | 42 | suppressed |
| Novolog Flexpen | Insulin Aspart | 42 | 17 |
| Colestipol Hcl | Colestipol Hcl | 41 | 14 |
| Lovastatin | Lovastatin | 41 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | 11 |
| Naproxen | Naproxen | 40 | suppressed |
| Telmisartan | Telmisartan | 40 | 12 |
| Meclizine Hcl | Meclizine Hcl | 39 | 11 |
| Methocarbamol | Methocarbamol | 39 | suppressed |
| Methylprednisolone | Methylprednisolone | 39 | 37 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 39 | 14 |
| Flecainide Acetate | Flecainide Acetate | 38 | suppressed |
| Glipizide | Glipizide | 38 | suppressed |
| Ondansetron Odt | Ondansetron | 38 | 23 |
| Tresiba Flextouch U-200 | Insulin Degludec | 38 | suppressed |
| Sucralfate | Sucralfate | 37 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 36 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 34 | suppressed |
| Celecoxib | Celecoxib | 34 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 33 | suppressed |
| Aripiprazole | Aripiprazole | 31 | 12 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 23 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 30 | suppressed |
| Primidone | Primidone | 30 | suppressed |
| Bumetanide | Bumetanide | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Metolazone | Metolazone | 27 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Amoxicillin | Amoxicillin | 26 | 15 |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 19 |
| Memantine Hcl | Memantine Hcl | 25 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 25 | suppressed |
| Nabumetone | Nabumetone | 24 | suppressed |
| Premarin | Estrogens, Conjugated | 24 | suppressed |
| Admelog Solostar | Insulin Lispro | 23 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Acyclovir | Acyclovir | 22 | suppressed |
| Jardiance | Empagliflozin | 22 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Nystatin | Nystatin | 21 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Sotalol | Sotalol Hcl | 20 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 14 |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 19 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Dutasteride | Dutasteride | 18 | suppressed |
| Galantamine Er | Galantamine Hbr | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 17 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Latanoprost | Latanoprost | 17 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 16 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Ingrezza | Valbenazine Tosylate | 15 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 12 |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 13 | suppressed |
| Repatha Sureclick | Evolocumab | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Armodafinil | Armodafinil | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Norethindrone Acetate | Norethindrone Acetate | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Indomethacin Er | Indomethacin | 11 | suppressed |
| Lamictal Xr | Lamotrigine | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $324.44 · 22 records | Novo Nordisk Inc | Auvelity, Cologuard Collection Kit, OTEZLA, Ozempic, REPATHA, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error